Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 71

1.

Whole-Genome Phage Display Libraries: A Powerful Tool for Antigen Discovery.

Beghetto E, Gargano N.

Methods Mol Biol. 2019;2024:181-198. doi: 10.1007/978-1-4939-9597-4_11.

PMID:
31364050
2.

Efficacy and Tolerability Outcomes of a Phase II, Randomized, Open-Label, Multicenter Study of a New Water-Dispersible Pediatric Formulation of Dihydroartemisinin-Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in African Infants.

Gargano N, Madrid L, Valentini G, D'Alessandro U, Halidou T, Sirima S, Tshefu A, Mtoro A, Gesase S; Eurartesim Dispersible Study Group, Bassat Q.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e00596-17. doi: 10.1128/AAC.00596-17. Print 2018 Jan.

3.

Antigen discovery using whole-genome phage display libraries.

Beghetto E, Gargano N.

Methods Mol Biol. 2013;1061:79-95. doi: 10.1007/978-1-62703-589-7_4.

PMID:
23963931
4.

Therapeutic efficacy and safety of dihydroartemisinin-piperaquine versus artesunate-mefloquine in uncomplicated Plasmodium falciparum malaria in India.

Gargano N, Ubben D, Tommasini S, Bacchieri A, Corsi M, Bhattacharyya PC, Rao BH, Dubashi N, Dev V, Ghosh SK, Kumar A, Srivastava B, Valecha N.

Malar J. 2012 Jul 20;11:233. doi: 10.1186/1475-2875-11-233.

5.

Antimalarial efficacy of piperaquine-based antimalarial combination therapies: facts and uncertainties.

Gargano N, Cenci F, Bassat Q.

Trop Med Int Health. 2011 Dec;16(12):1466-73. doi: 10.1111/j.1365-3156.2011.02855.x. Epub 2011 Sep 13. Review.

6.

Lambda-display: a powerful tool for antigen discovery.

Beghetto E, Gargano N.

Molecules. 2011 Apr 13;16(4):3089-105. doi: 10.3390/molecules16043089. Review.

7.

Toxoplasma gondii Dense Granule Antigen 1 stimulates apoptosis of monocytes through autocrine TGF-β signaling.

D'Angelillo A, De Luna E, Romano S, Bisogni R, Buffolano W, Gargano N, Del Porto P, Del Vecchio L, Petersen E, Romano MF.

Apoptosis. 2011 Jun;16(6):551-62. doi: 10.1007/s10495-011-0586-0.

PMID:
21390541
8.

Use of recombinant chimeric antigens for the serodiagnosis of Mycoplasma pneumoniae infection.

Montagnani F, De Paolis F, Beghetto E, Gargano N.

Eur J Clin Microbiol Infect Dis. 2010 Nov;29(11):1377-86. doi: 10.1007/s10096-010-1010-3. Epub 2010 Jul 15.

PMID:
20632053
9.

Toxoplasma vaccines: appropriate end points and sample size in future human clinical trials.

Silveira C, Gargano N, Kijlstra A, Petersen E.

Expert Rev Anti Infect Ther. 2009 Oct;7(8):905-8. doi: 10.1586/eri.09.81. No abstract available.

PMID:
19803697
10.

Vaccines against Toxoplasma gondii: challenges and opportunities.

Jongert E, Roberts CW, Gargano N, Förster-Waldl E, Petersen E.

Mem Inst Oswaldo Cruz. 2009 Mar;104(2):252-66. Review. Erratum in: Mem Inst Oswaldo Cruz. 2010 Feb;105(1):following 116. Förster-Wald, Elisabeth [corrected to Förster-Waldl, Elisabeth].

11.

Induction of partial protection against infection with Toxoplasma gondii genotype II by DNA vaccination with recombinant chimeric tachyzoite antigens.

Rosenberg C, De Craeye S, Jongert E, Gargano N, Beghetto E, Del Porto P, Vorup-Jensen T, Petersen E.

Vaccine. 2009 Apr 21;27(18):2489-98. doi: 10.1016/j.vaccine.2009.02.058. Epub 2009 Feb 24.

PMID:
19368791
12.

Impact of viral selected mutations on T cell mediated immunity in chronically evolving and self limiting acute HCV infection.

Guglietta S, Garbuglia AR, Salichos L, Ruggeri L, Folgori A, Perrone MP, Camperio C, Mellace V, Maio G, Maio P, Capobianchi MR, Spada E, Gargano N, Scottà C, Piccolella E, Del Porto P.

Virology. 2009 Apr 10;386(2):398-406. doi: 10.1016/j.virol.2009.01.020. Epub 2009 Feb 20.

13.

Discovery of new Mycoplasma pneumoniae antigens by use of a whole-genome lambda display library.

Beghetto E, De Paolis F, Montagnani F, Cellesi C, Gargano N.

Microbes Infect. 2009 Jan;11(1):66-73. doi: 10.1016/j.micinf.2008.10.004. Epub 2008 Oct 21.

PMID:
18992837
14.

Protective Th1 immune responses against chronic toxoplasmosis induced by a protein-protein vaccine combination but not by its DNA-protein counterpart.

Jongert E, Verhelst D, Abady M, Petersen E, Gargano N.

Vaccine. 2008 Sep 26;26(41):5289-95. doi: 10.1016/j.vaccine.2008.07.032. Epub 2008 Aug 27.

PMID:
18675872
15.

Molecular dissection of the human B cell response against cytomegalovirus infection by lambda display.

Beghetto E, Paolis FD, Spadoni A, Del Porto P, Buffolano W, Gargano N.

J Virol Methods. 2008 Jul;151(1):7-14. doi: 10.1016/j.jviromet.2008.04.005. Epub 2008 May 21.

PMID:
18499273
16.

Identification of a human immunodominant B-cell epitope within the immunoglobulin A1 protease of Streptococcus pneumoniae.

De Paolis F, Beghetto E, Spadoni A, Montagnani F, Felici F, Oggioni MR, Gargano N.

BMC Microbiol. 2007 Dec 18;7:113.

17.

Age-dependent impairment of functional helper T cell responses to immunodominant epitopes of Toxoplasma gondii antigens in congenitally infected individuals.

Guglietta S, Beghetto E, Spadoni A, Buffolano W, Del Porto P, Gargano N.

Microbes Infect. 2007 Feb;9(2):127-33. Epub 2006 Dec 6.

PMID:
17223600
18.

A novel approach for identification of tumor-associated antigens expressed on the surface of tumor cells.

Di Cristina M, Minenkova O, Pavoni E, Beghetto E, Spadoni A, Felici F, Gargano N.

Int J Cancer. 2007 Mar 15;120(6):1293-303.

19.

Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome lambda-display library.

Beghetto E, Gargano N, Ricci S, Garufi G, Peppoloni S, Montagnani F, Oggioni M, Pozzi G, Felici F.

FEMS Microbiol Lett. 2006 Sep;262(1):14-21.

20.

Chimeric antigens of Toxoplasma gondii: toward standardization of toxoplasmosis serodiagnosis using recombinant products.

Beghetto E, Spadoni A, Bruno L, Buffolano W, Gargano N.

J Clin Microbiol. 2006 Jun;44(6):2133-40.

21.

Toxoplasma gondii: DNA vaccination with bradyzoite antigens induces protective immunity in mice against oral infection with parasite cysts.

Nielsen HV, Di Cristina M, Beghetto E, Spadoni A, Petersen E, Gargano N.

Exp Parasitol. 2006 Apr;112(4):274-9. Epub 2005 Dec 20.

PMID:
16368092
22.

Use of recombinant antigens for early postnatal diagnosis of congenital toxoplasmosis.

Buffolano W, Beghetto E, Del Pezzo M, Spadoni A, Di Cristina M, Petersen E, Gargano N.

J Clin Microbiol. 2005 Dec;43(12):5916-24.

23.

A combination of antigenic regions of Toxoplasma gondii microneme proteins induces protective immunity against oral infection with parasite cysts.

Beghetto E, Nielsen HV, Del Porto P, Buffolano W, Guglietta S, Felici F, Petersen E, Gargano N.

J Infect Dis. 2005 Feb 15;191(4):637-45. Epub 2005 Jan 14.

PMID:
15655789
24.

Delayed maturation of IgG avidity in congenital toxoplasmosis.

Buffolano W, Lappalainen M, Hedman L, Ciccimarra F, Del Pezzo M, Rescaldani R, Gargano N, Hedman K.

Eur J Clin Microbiol Infect Dis. 2004 Nov;23(11):825-30. Epub 2004 Oct 19.

PMID:
15558340
25.

The Toxoplasma gondii bradyzoite antigens BAG1 and MAG1 induce early humoral and cell-mediated immune responses upon human infection.

Di Cristina M, Del Porto P, Buffolano W, Beghetto E, Spadoni A, Guglietta S, Piccolella E, Felici F, Gargano N.

Microbes Infect. 2004 Feb;6(2):164-71.

PMID:
14998514
26.

Use of an immunoglobulin G avidity assay based on recombinant antigens for diagnosis of primary Toxoplasma gondii infection during pregnancy.

Beghetto E, Buffolano W, Spadoni A, Del Pezzo M, Di Cristina M, Minenkova O, Petersen E, Felici F, Gargano N.

J Clin Microbiol. 2003 Dec;41(12):5414-8.

27.

Identification of tumor-associated antigens by screening phage-displayed human cDNA libraries with sera from tumor patients.

Minenkova O, Pucci A, Pavoni E, De Tomassi A, Fortugno P, Gargano N, Cianfriglia M, Barca S, De Placido S, Martignetti A, Felici F, Cortese R, Monaci P.

Int J Cancer. 2003 Sep 10;106(4):534-44.

28.

Molecular dissection of the human B-cell response against Toxoplasma gondii infection by lambda display of cDNA libraries.

Beghetto E, Spadoni A, Buffolano W, Del Pezzo M, Minenkova O, Pavoni E, Pucci A, Cortese R, Felici F, Gargano N.

Int J Parasitol. 2003 Feb;33(2):163-73.

PMID:
12633654
29.

Identification of a human immunodominant B-cell epitope within the GRA1 antigen of Toxoplasma gondii by phage display of cDNA libraries.

Beghetto E, Pucci A, Minenkova O, Spadoni A, Bruno L, Buffolano W, Soldati D, Felici F, Gargano N.

Int J Parasitol. 2001 Dec;31(14):1659-68.

PMID:
11730793
30.

ADAM-HCV, a new-concept diagnostic assay for antibodies to hepatitis C virus in serum.

Minenkova O, Gargano N, De Tomassi A, Bellintani F, Pucci A, Fortugno P, Fuscaldi E, Pessi A, Rapicetta M, Miceli M, Iudicone P, Cortese R, Felici F, Monaci P.

Eur J Biochem. 2001 Sep;268(17):4758-68.

31.

Colony assay for phage-displayed libraries.

Minenkova O, De Tomassi A, Bellintani F, Fortugno P, Gargano N, Felici F, Monaci P.

Anal Biochem. 2000 Sep 10;284(2):412-5. No abstract available.

PMID:
10964429
33.

Modulation of nerve growth factor internalization by direct interaction between p75 and TrkA receptors.

Gargano N, Levi A, Alema S.

J Neurosci Res. 1997 Oct 1;50(1):1-12.

PMID:
9379485
36.
37.

Neuronal differentiation of P19 embryonal cells exhibits cell-specific regulation of neurotrophin receptors.

Salvatore AM, Cozzolino M, Gargano N, Galanti S, Levi A, Alemà S.

Neuroreport. 1995 Apr 19;6(6):873-7.

PMID:
7542037
38.

Immunohistochemical detection of high-affinity nerve growth factor receptor in neuroblastoma.

Dominici C, Nicotra MR, Digiesi G, McDowell H, Alemà S, Padula A, Gargano N, Donfrancesco A, Castello MA, Natali PG.

Eur J Cancer. 1995;31A(4):444-6.

PMID:
7576942
39.

[Primary cutaneous cryptococcosis. Apropos of a case].

Varotti C, Patrone P, Mazzoni A, Gargano N, Passarini B.

G Ital Dermatol Venereol. 1986 Sep-Oct;121(5):349-50. Italian. No abstract available.

PMID:
3793145
40.

[Hepatopathy and lichen ruber planus].

Patrone P, Reggiani M, Minghetti G, Gargano N, Patrizi A.

G Ital Dermatol Venereol. 1986 Mar-Apr;121(2):79-81. Italian. No abstract available.

PMID:
3710533
41.

[Nail changes and alopecia areata].

Tosti A, De Padova MP, Caponeri GM, Liverani L, Gargano N, Veronesi S.

G Ital Dermatol Venereol. 1985 May-Jun;120(3):169-71. Italian. No abstract available.

PMID:
4030012
43.

[Influence of the relative environmental humidity on some respiratory function tests in subjects with pulmonary silicosis].

Bellini PG, Gargano N, Giannone S.

Boll Soc Ital Biol Sper. 1970 Sep 15;46(17):676-9. Italian. No abstract available.

PMID:
5498682
44.

[Hemodynamic effects of prolonged treatment with triamterene in hypertensive subjects].

Ciampolini E, Gargano N, Grazi S, Libretti A.

Boll Soc Ital Cardiol. 1965;10(1):14-20. Italian. No abstract available.

PMID:
5900030
45.

[IMPORTANCE OF THE STATE OF SODIUM RETENTION AND GLOMERULO-TUBULAR INTERACTIONS IN EVALUATION OF THE DIURETIC ACTIVITY OF FUROSEMIDE].

GARGANO N, ANICHINI M, CORTIGIANI C.

Clin Ter. 1964 Dec 31;31:544-60. Italian. No abstract available.

PMID:
14266405
46.

[SECONDARY ASPECIFIC EFFECTS OF BENZOTHIAZINIC DIURETICS].

ANICHINI M, GARGANO N, BARTORELLI C.

Minerva Med. 1964 Sep 8;55:2651-6. Italian. No abstract available.

PMID:
14204435
47.

[Action of angiotensin on the urinary secretion of electrolytes in the normotensive dog].

Gargano N, Anichini M, Leonetti G.

Boll Soc Ital Biol Sper. 1964 Mar 31;40(6):259-62. Italian. No abstract available.

PMID:
4290645
48.

[Effects of the prolonged administration of triamterene in arterial hypertensive patients].

Gargano N.

Minerva Med. 1963 Oct 10;54(81 Suppl):3043-6. Italian. No abstract available.

PMID:
5877339
49.

[CLINICAL PHARMACOLOGY OF DIURETICS].

GARGANO N.

Riforma Med. 1963 Sep 14;77:1036-43. Review. Italian. No abstract available.

PMID:
14093351
50.

[ON THE MECHANISM OF THE HYPOTENSIVE ACTION OF DIURETICS: INFLUENCE, ON ARTERIAL PRESSURE, OF REDUCTIONS OF BLOOD VOLUME INDUCED BY TRIAMTERENE].

ANICHINI M, GARGANO N, LEONETTI G.

Boll Soc Ital Biol Sper. 1963 Jul 31;39:803-6. Italian. No abstract available.

PMID:
14067635

Supplemental Content

Loading ...
Support Center